Tuesday November 24 2009 | Biotechnology feed | All feeds
|
|
Azevan Pharmaceuticals, Inc.
Download detailed PDF Members: Azevan Pharmaceuticals, Inc. (Azevan or the Company) is developing novel therapeutics for the treatment of disorders of stress, mood, and behavior. The Company leverages its expertise in behavioral neurobiology with its proprietary chemistry platform targeting G-protein coupled receptors (GPCRs) to create drug candidates. Azevan’s first series of clinical candidates selectively block the effects of arginine vasopressin (AVP), which is involved in the pathophysiology of various conditions including stress-related affective illness, impulsivity/inappropriate aggression, and menstrual-related disorders.
This page has been viewed 550 times since April 2007, the link to the organisation's website has been followed 76 times Recent Search Terms used to find this page: Azevan Pharmaceuticals Inc. | azevan pharmaceuticals | azevan pharmaceuticals | Azevan | Azevan Pharmaceuticals Inc. | Azevan Pharmaceuticals | Azevan Pharmaceuticals | value proposition for pharmaceuticals | azevan | Search Azevan Pharmaceuticals | . Search for more companies in Bethlehem Search for more companies in Pennsylvania This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Azevan Pharmaceuticals, Inc. | ||||||||||||||||||||||||||||||||||
|